Newstrike Resources Ltd. Consents to Postponement of CanniMed Therapeutics' Special Shareholders' Meeting

TORONTO, ONTARIO--(Marketwired - Jan. 18, 2018) - Newstrike Resources Ltd. ("Newstrike" or the "Company") (TSX VENTURE:HIP) announces it has consented to the postponement by CanniMed Therapeutics Inc. ("CanniMed") of the special meeting of CanniMed shareholders (the "Meeting") originally scheduled for January 23, 2018, to Thursday, January 25 at 10:00 am (EST).

CanniMed has determined to postpone the Meeting to allow discussions regarding a possible transaction with Aurora Cannabis Inc. ("Aurora") as permitted under the terms of the Arrangement Agreement between CanniMed and Newstrike, dated November 17, 2017. There is no certainty that any such discussion will result in an agreement among the parties in respect of a transaction or in any change to the terms of Aurora's offer with respect to CanniMed dated November 24, 2017 (as amended).

CanniMed and Aurora have each agreed to a standstill until January 21, 2018 at 11:59 pm (EST), and until such time, and in connection therewith (i) neither CanniMed nor Aurora will solicit any proxies of CanniMed shareholders, (ii) Aurora will not, directly or indirectly, acquire control or direction over any additional shares of CanniMed, (iii) neither CanniMed nor Aurora will make any announcement or public statements in respect of a potential transaction nor will Aurora make or publicly announce any changes to its offer dated November 24, 2017 (as amended) unless mutually agreed; and (iv) neither CanniMed nor Aurora will solicit an alternative transaction or enter into any discussions or negotiations with respect to an alternative transaction during the standstill period.

The Meeting has been called to consider an ordinary resolution of the shareholders of CanniMed approving the issuance or reservation for issuance of such number of common shares of CanniMed as may be required pursuant to the plan of arrangement relating to the acquisition by CanniMed of Newstrike (the "Plan of Arrangement"), all as more particular described in the management information circular of CanniMed dated December 8, 2017 available at www.sedar.com. The Meeting will proceed on January 25, 2018 unless adjourned or postponed further.